670 related articles for article (PubMed ID: 17389667)
1. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
Dale KM; White CM
Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
[TBL] [Abstract][Full Text] [Related]
2. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
Garcia D; Cheng-Lai A
Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
[TBL] [Abstract][Full Text] [Related]
3. Dronedarone.
Patel C; Yan GX; Kowey PR
Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
[TBL] [Abstract][Full Text] [Related]
4. Dronedarone: an alternative to amiodarone?
Hughes PJ; Freeman MK; Cohenour FV; Price EM
Consult Pharm; 2010 Sep; 25(9):555-69. PubMed ID: 20876046
[TBL] [Abstract][Full Text] [Related]
5. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
[TBL] [Abstract][Full Text] [Related]
6. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
Duray GZ; Ehrlich JR; Hohnloser SH
Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
[TBL] [Abstract][Full Text] [Related]
7. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
Wegener FT; Ehrlich JR; Hohnloser SH
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
[TBL] [Abstract][Full Text] [Related]
9. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
Prescrire Int; 2010 Aug; 19(108):149-52. PubMed ID: 20939439
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dronedarone: a review of randomized trials.
Christiansen CB; Torp-Pedersen C; Køber L
Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
[TBL] [Abstract][Full Text] [Related]
11. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
12. Dronedarone: a review of characteristics and clinical data.
Baroletti S; Catella J; Ehle M; Cheng JW
Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
[TBL] [Abstract][Full Text] [Related]
13. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
Duray GZ; Schmitt J; Hohnloser SH
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
[TBL] [Abstract][Full Text] [Related]
14. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
Krishnamoorthy S; Lip GY
Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
[TBL] [Abstract][Full Text] [Related]
16. Dronedarone for atrial fibrillation therapy.
Marzocchi M; Lombardi F
Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
[TBL] [Abstract][Full Text] [Related]
17. Dronedarone (Multaq) for atrial fibrillation.
Med Lett Drugs Ther; 2009 Oct; 51(1322):78-80. PubMed ID: 19798011
[TBL] [Abstract][Full Text] [Related]
18. Dronedarone: current evidence and future questions.
Schafer JA; Kjesbo NK; Gleason PP
Cardiovasc Ther; 2010; 28(1):38-47. PubMed ID: 20074258
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
Rosa GM; Bianco D; Parodi A; Valbusa A; Zawaideh C; Bizzarri N; Ferrero S; Brunelli C
Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1751-64. PubMed ID: 25349898
[TBL] [Abstract][Full Text] [Related]
20. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
